|
CASC5 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.856000E-02 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.092190E-01 |
| Normal-vs-Stage2 |
1.257780E-02 |
| Normal-vs-Stage3 |
6.519600E-02 |
| Normal-vs-Stage4 |
1.975640E-01 |
| Stage1-vs-Stage2 |
2.542900E-03 |
| Stage1-vs-Stage3 |
3.803200E-01 |
| Stage1-vs-Stage4 |
7.372000E-01 |
| Stage2-vs-Stage3 |
1.024210E-01 |
| Stage2-vs-Stage4 |
4.601800E-02 |
| Stage3-vs-Stage4 |
3.945400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.235360E-01 |
| Normal-vs-AfricanAmerican |
1.246980E-01 |
| Normal-vs-Asian |
4.903500E-02 |
| Caucasian-vs-AfricanAmerican |
8.100000E-01 |
| Caucasian-vs-Asian |
1.783650E-01 |
| AfricanAmerican-vs-Asian |
5.501000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.653800E-02 |
| Normal-vs-Female |
8.762100E-02 |
| Male-vs-Female |
5.747200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.985420E-01 |
| Normal-vs-Age(41-60Yrs) |
2.574300E-02 |
| Normal-vs-Age(61-80Yrs) |
8.088300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.934600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.883430E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.081600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.881200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.882000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.466450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.966800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.024200E-01 |
| Classical-VS-Follicular |
1.87836999999691E-05 |
| Classical-VS-Other |
2.132200E-01 |
| Classical-VS-Normal |
1.566180E-01 |
| Tall-VS-Follicular |
5.320100E-02 |
| Tall-VS-Other |
1.229240E-01 |
| Tall-VS-Normal |
3.118600E-01 |
| Follicular-VS-Other |
9.855000E-01 |
| Follicular-VS-Normal |
8.158500E-03 |
| Other-VS-Normal |
2.144200E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.800500E-02 |
| Normal-vs-N1 |
4.222400E-02 |
| N0-vs-N1 |
7.755400E-01 |
|
|
